Drug combination shows effectiveness in patients with recurrent ER-positive endometrial cancer - Medical Xpress
3/20/2022 12:00:00 AM3 years 1 month ago
by Science X staff
by Science X staff
A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from a recent clinical trial show. Trial…
A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometr… [+3730 chars]
full article...